↓ Skip to main content

Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial

Overview of attention for article published in Journal of Clinical Oncology, November 2009
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Citations

dimensions_citation
551 Dimensions

Readers on

mendeley
539 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Published in
Journal of Clinical Oncology, November 2009
DOI 10.1200/jco.2009.23.2488
Pubmed ID
Authors

Daniel A. Galvão, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton

Abstract

Androgen suppression therapy (AST) results in musculoskeletal toxicity that reduces physical function and quality of life. This study examined the impact of a combined resistance and aerobic exercise program as a countermeasure to these AST-related toxicities.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 539 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 <1%
Canada 3 <1%
Denmark 2 <1%
Australia 2 <1%
United States 2 <1%
Japan 1 <1%
Switzerland 1 <1%
Unknown 524 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 96 18%
Student > Bachelor 70 13%
Student > Ph. D. Student 65 12%
Researcher 55 10%
Student > Postgraduate 26 5%
Other 110 20%
Unknown 117 22%
Readers by discipline Count As %
Medicine and Dentistry 158 29%
Sports and Recreations 74 14%
Nursing and Health Professions 63 12%
Agricultural and Biological Sciences 27 5%
Social Sciences 17 3%
Other 67 12%
Unknown 133 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2022.
All research outputs
#1,110,514
of 25,373,627 outputs
Outputs from Journal of Clinical Oncology
#2,704
of 22,043 outputs
Outputs of similar age
#4,126
of 176,920 outputs
Outputs of similar age from Journal of Clinical Oncology
#7
of 150 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,920 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.